Neuroprotective Effect of Kaempferol Glycosides against Brain Injury and Neuroinflammation by Inhibiting the Activation of NF-κB and STAT3 in Transient Focal Stroke

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Yu, Lu ^a,c   Chen, Chu ^b   Wang, Liang Fen ^a   Kuang, Xi ^a   Liu, Ke ^a   Zhang, Hao ^a   Du, Jun Rong ^a  

^a SICHUAN UNIVERSITY   (China)

^b Sichuan Academy of Traditional Chinese Medicine Sciences   (China)

^c SOUTHWEST MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; ASTRAGALIN; CD11B ANTIGEN; GELATINASE B; GLIAL FIBRILLARY ACIDIC PROTEIN; GLYCOPROTEIN P 15095; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; MYELOPEROXIDASE; NICOTIFLORIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; AXONAL INJURY; BRAIN INFARCTION SIZE; BRAIN INJURY; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG EFFICACY; HEMISPHERE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MICROGLIA; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL LESION; NERVOUS SYSTEM INFLAMMATION; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; RAT; REPERFUSION; TRANSIENT ISCHEMIC ATTACK; UPREGULATION; WESTERN BLOTTING;

ANIMALS; ASTROCYTES; AXONS; BRAIN INJURIES; CEREBRAL INFARCTION; INFARCTION, MIDDLE CEREBRAL ARTERY; INFLAMMATION; INFLAMMATION MEDIATORS; KAEMPFEROLS; MALE; MICROGLIA; MONOSACCHARIDES; NEUROPROTECTIVE AGENTS; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY; STAT3 TRANSCRIPTION FACTOR; STROKE;

EID: 84874264724     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055839     Document Type: Article

References (36)

1. Molina CA, Alvarez-Sabín J, (2009) Recanalization and reperfusion therapies for acute ischemic stroke. Cerebrovasc Dis 27: S162-S167.
2. Durukan A, Tatlisumak T, (2007) Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol Biochem Behav 87: 179-197.
3. Lakhan SE, Kirchgessner A, Hofer M, (2009) Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J Transl Med 7: 97.
4. Muir KW, Tyrrell P, Sattar N, Warburton E, (2007) Inflammation and ischaemic stroke. Curr Opin Neurol 20: 334-342.
5. Yi JH, Park SW, Kapadia R, Vemuganti R, (2007) Role of transcription factors in mediating post-ischemic cerebral inflammation and brain damage. Neurochem Int 50: 1014-1027.
6. del Zoppo GJ, (2010) The neurovascular unit in the setting of stroke. J Intern Med 267: 156-171.
7. del Zoppo GJ, Schmid-Schönbein GW, Mori E, Copeland BR, Chang CM, (1991) Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons. Stroke 22: 1276-1283.
8. Hamann GF, Okada Y, del Zoppo GJ, (1996) Hemorrhagic transformation and microvascular integrity during focal cerebral ischemia/ reperfusion. J Cereb Blood Flow Metab 16: 1373-1378.
9. Shi F, Liu YW, (2006) The chemical components and the pharmacological studies progress of Carthamus. Li Shi Zhen Med Materia Medica Res 17: 1666-1667.
10. Middleton E Jr, Kandaswami C, Theoharides TC, (2000) The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 52: 673-751.
11. Huang JL, Fu ST, Jiang YY, Cao YB, Guo ML, et al. (2007) Protective effects of Nicotiflorin on reducing memory dysfunction, energy metabolism failure and oxidative stress in multi-infarct dementia model rats. Pharmacol Biochem Behav 86: 741-748.
12. Li R, Guo M, Zhang G, Xu X, Li Q, (2006) Nicotiflorin reduces cerebral ischemic damage and upregulates endothelial nitric oxide synthase in primarily cultured rat cerebral blood vessel endothelial cells. J Ethnopharmacol 107: 143-150.
13. Parveen Z, Deng Y, Saeed MK, Dai R, Ahamad W, et al. (2007) Anti- inflammatory and analgesic activities of Thesium chinense Turcz extracts and its major flavonoids, kaempferol and kaempferol-3-O-glucoside. Yakugaku Zasshi 127: 1275-1279.
14. Autore G, Rastrelli L, Lauro MR, Marzocco S, Sorrentino R, et al. (2001) Inhibition of nitric oxide synthase expression by a methanolic extract of Crescentia alata and its derived flavonols. Life Sci 70: 523-534.
15. Oh H, Kim DH, Cho JH, Kim YC, (2004) Hepatoprotective and free radical scavenging activities of phenolic petrosins and flavonoids isolated from Equisetum arvense. J Ethnopharmacol 95: 421-424.
16. Yu D, Cheng YS, Hu SQ, Zheng H, (2010) Determination of total flavonoids and kaempferol-3-O-rutinoside in Safflower produced in Sichuan and Safflower variety named white flower. West China J Pharmaceu Sci 25: 751-753.
17. Longa EZ, Weinstein PR, Carlson S, Cummins R, (1989) Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20: 84-91.
18. Peng HY, Du JR, Zhang GY, Kuang X, Liu YX, et al. (2007) Neuroprotective effect of Z-ligustilide against permanent focal ischemic damage in rats. Biol Pharm Bull 30: 309-312.
19. Chen Y, Wu X, Yu S, Lin X, Wu J, et al. (2012) Neuroprotection of tanshinone IIA against cerebral ischemia/reperfusion injury through inhibition of macrophage migration inhibitory factor in rats. PLoS One 7: e40165.
20. Kuang X, Du JR, Chen YS, Wang J, Wang YN, (2009) Protective effect of Z-ligustilide against amyloid beta-induced neurotoxicity is associated with decreased pro- inflammatory markers in rat brains. Pharmacol Biochem Behav 92: 635-641.
21. Chu K, Lee ST, Koo JS, Jung KH, Kim EH, et al. (2006) Peroxisome proliferator--activated receptor-gamma-agonist, rosiglitazone, promotes angiogenesis after focal cerebral ischemia. Brain Res 1093: 208-218.
22. Park SE, Sapkota K, Kim S, Kim H, Kim SJ, (2011) Kaempferol acts through mitogen- activated protein kinases and protein kinase B/AKT to elicit protection in a model of neuroinflammation in BV2 microglial cells. Br J Pharmacol 164: 1008-1025.
23. Liu F, Schafer DP, McCullough LD, (2009) TTC, Fluoro-Jade B and NeuN staining confirm evolving phases of infarction. J Neurosci Methods 179: 1-8.
24. Medana IM, Esiri MM, (2003) Axonal damage: a key predictor of outcome in human CNS diseases. Brain 126: 515-530.
25. Gresle MM, Jarrott B, Jones NM, Callaway JK, (2006) Injury to axons and oligodendrocytes following endothelin-1-induced middle cerebral artery occlusion in conscious rats. Brain Res 110: 13-22.
26. Dewar D, Dawson D, (1995) Tau protein is altered by focal cerebral ischaemia in the rat: an immunohistochemical and immunoblotting study. Brain Res 684: 70-78.
27. Schilling M, Besselmann M, Leonhard C, Mueller M, Ringelstein EB, et al. (2003) Microglial activation precedes and predominates over macrophage infiltration in transient focal cerebral ischemia: a study in green fluorescent protein transgenic bone marrow chimeric mice. Exp Neurol 183: 25-33.
28. Swanson RA, Ying W, Kauppinen TM, (2004) Astrocyte influences on ischemic neuronal death. Curr Mol Med 4: 193-205.
29. Bromberg J, Darnell JE Jr, (2000) The role of STATs in transcriptional control and their impact on cellular function. Oncogene 19: 2468-2473.
30. Satriotomo I, Bowen KK, Vemuganti R, (2006) JAK2 and STAT3 activation contributes to neuronal damage following transient focal cerebral ischemia. J Neurochem 98: 1353-1368.
31. Suzuki S, Tanaka K, Nogawa S, Dembo T, Kosakai A, et al. (2001) Phosphorylation of signal transducer and activator of transcription-3(STAT3) after focal cerebral ischemia in rats. Exp Neurol 170: 63-71.
32. Sasaki CY, Barberi TJ, Ghosh P, Longo DL, (2005) Phosphorylation of RelA/p65 on serine 536 defines an IκBα-independent NF-κB pathway. J Biol Chem 280: 34538-34547.
33. Kunz A, Abe T, Hochrainer K, Shimamura M, Anrather J, et al. (2008) Nuclear factor κB activation and postischemic inflammation are suppressed in CD36- null mice after middle cerebral artery occlusion. J Neurosci 28: 1649-1658.
34. Emerich DF, Dean RL 3rd, Bartus RT (2002) The role of leukocytes following cerebral ischemia: pathogenic variable or bystander reaction to emerging infarct? Exp Neurol 173: 168-181.
35. Tsuji K, Aoki T, Tejima E, Arai K, Lee SR, et al. (2005) Tissue plasminogen activator promotes matrix metallop- roteinase-9 up regulation after focal cerebral ischemia. Stroke 36: 1954-1959.
36. Weston RM, Jones NM, Jarrott B, Callaway JK, (2007) Inflammatory cell infiltration after endothelin-1-induced cerebral ischemia: Histochemical and myeloperoxidase correlation with temporal changes in brain injury. J Cereb Blood Flow Metab 27: 100-114.